The effects of extracellular magnesium on myoplasmic [Ca2+] in malignant hyperthermia susceptible swine.
It is now well established that the pathophysiology of the malignant hyperthermia (MH) syndrome is related to a malfunction of intracellular calcium homeostasis. Magnesium plays important roles in the basic contractile properties of muscle, and many of its actions are antagonistic to those of calcium. The aim of this study was to determine the effectiveness of magnesium sulphate to prevent the MH episode in susceptible animals and correlate this with its effects on the intracellular free calcium [( Ca2+]i). The experiments were carried out using six control (Yorkshire) and ten MH-susceptible crossbred swine (Poland China X Pietrain). After determination of resting concentrations of [Ca2+]i and [Mg2+]i, each animal was given either two iv bolus doses of 50 mg/kg or one iv bolus of 100 mg/kg of MgSO4. The resting [Ca2+]i and [Mg2+]i were determined by means of ion-selective microelectrodes. The resting [Ca2+]i in normal muscle fibers was 0.11 +/- 0.01 microM (mean +/- SEM), whereas in the MH muscles the resting [Ca2+]i was 0.36 +/- 0.01 microM. In neither group was the resting [Ca2+]i modified by MgSO4. This cumulative dose of MgSO4 (100 mg/kg) was not able to prevent the induction of an MH episode by 2% halothane. Although MgSO4 did not directly decrease [Ca2+]i, it did attenuate the increase in [Ca2+]i associated with the syndrome from 7.29 +/- 0.43 microM in untreated animals to 0.84 +/- 0.03 microM in MgSO4 pretreated swine. In addition, the limb rigidity that accompanies this increase in calcium was prevented by MgSO4 pretreatment. Baseline measurements of [Mg2+]i were not different in control and MH-susceptible muscles.(ABSTRACT TRUNCATED AT 250 WORDS)
Lopez
J R
JR
Centro de Biofisica y Bioquimica, Instituto Venezolano de Investigaciones Cientificas, Caracas, Venezuela.
Sanchez
V
V
Lopez
I
I
Ryan
J F
JF
Mendoza
M
M
Sreter
F A
FA
Allen
P D
PD
D000818:Animals; D002118:Calcium / Q000032:analysis / Q000378:metabolism*; D003620:Dantrolene / Q000494:pharmacology; D004198:Disease Susceptibility; D005110:Extracellular Space / Q000187:drug effects / Q000378:metabolism; D006221:Halothane / Q000494:pharmacology; D008278:Magnesium Sulfate / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008305:Malignant Hyperthermia / Q000378:metabolism / Q000517:prevention & control*; D008564:Membrane Potentials / Q000187:drug effects; D008839:Microelectrodes; D009132:Muscles / Q000187:drug effects* / Q000378:metabolism; D013045:Species Specificity; D013552:Swine
D008278:Magnesium Sulfate; D003620:Dantrolene; D002118:Calcium; D006221:Halothane